IT8821542A0 - Composti attivi come inibitori della biosintesi del colesterolo. - Google Patents
Composti attivi come inibitori della biosintesi del colesterolo.Info
- Publication number
- IT8821542A0 IT8821542A0 IT8821542A IT2154288A IT8821542A0 IT 8821542 A0 IT8821542 A0 IT 8821542A0 IT 8821542 A IT8821542 A IT 8821542A IT 2154288 A IT2154288 A IT 2154288A IT 8821542 A0 IT8821542 A0 IT 8821542A0
- Authority
- IT
- Italy
- Prior art keywords
- inhibitors
- active compounds
- cholesterol biosynthesis
- biosynthesis
- cholesterol
- Prior art date
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title 2
- 230000015572 biosynthetic process Effects 0.000 title 1
- 235000012000 cholesterol Nutrition 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8821542A IT1226726B (it) | 1988-07-29 | 1988-07-29 | Composti attivi come inibitori della biosintesi del colesterolo. |
EP19890201957 EP0352864A3 (en) | 1988-07-29 | 1989-07-25 | Compounds active as inhibitors of the cholesterol biosynthesis |
US07/385,369 US4940800A (en) | 1988-07-29 | 1989-07-27 | Beazimidazole compounds active as inhibitors of the cholesterol biosynthesis |
JP89197895A JPH02250870A (ja) | 1988-07-28 | 1989-07-28 | コレステロール生合成抑制性化合物 |
US07/519,444 US5196440A (en) | 1988-07-29 | 1990-05-04 | Compounds active as inhibitors of the cholesterol biosynthesis |
US07/719,103 US5468746A (en) | 1988-07-29 | 1991-06-21 | Compounds active on the cardiovascular system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8821542A IT1226726B (it) | 1988-07-29 | 1988-07-29 | Composti attivi come inibitori della biosintesi del colesterolo. |
Publications (2)
Publication Number | Publication Date |
---|---|
IT8821542A0 true IT8821542A0 (it) | 1988-07-29 |
IT1226726B IT1226726B (it) | 1991-02-05 |
Family
ID=11183343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT8821542A IT1226726B (it) | 1988-07-28 | 1988-07-29 | Composti attivi come inibitori della biosintesi del colesterolo. |
Country Status (4)
Country | Link |
---|---|
US (1) | US4940800A (it) |
EP (1) | EP0352864A3 (it) |
JP (1) | JPH02250870A (it) |
IT (1) | IT1226726B (it) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1237792B (it) * | 1989-12-21 | 1993-06-17 | Zambon Spa | Composti attivi come inibitori dell'enzima hmg-coa reduttasi |
US5387600A (en) * | 1992-07-30 | 1995-02-07 | Fuji Photo Film Co., Ltd. | Treating arteriosclerosis using benzimidazole compositions |
EP0849259A4 (en) * | 1995-07-17 | 1998-11-11 | Fuji Photo Film Co Ltd | BENZIMIDAZOLE COMPOUNDS |
ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
US6075040A (en) * | 1996-09-05 | 2000-06-13 | Eli Lilly And Company | Selective β3 adrenergic agonists |
EP0827746B1 (en) | 1996-09-05 | 2002-04-03 | Eli Lilly And Company | Carbazole analogues as selective beta3 adrenergic agonists |
US20010006644A1 (en) | 1997-07-31 | 2001-07-05 | David J. Bova | Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night |
CO5011072A1 (es) | 1997-12-05 | 2001-02-28 | Lilly Co Eli | Etanolaminas pirazinil substituidas como agfonistas de los receptores |
RU2233654C2 (ru) | 1998-11-20 | 2004-08-10 | Ртп Фарма Инк. | Диспергируемые стабилизированные фосфолипидом микрочастицы |
WO2001056596A1 (en) * | 2000-02-04 | 2001-08-09 | Children's Hospital Research Foundation | Use of lysosomal acid lipase for treating atherosclerosis and related diseases |
US8586094B2 (en) | 2000-09-20 | 2013-11-19 | Jagotec Ag | Coated tablets |
CN101880227A (zh) * | 2001-07-06 | 2010-11-10 | 西巴特殊化学品控股有限公司 | 一种用于制备适合于制备他汀类衍生物的中间体化合物的方法及其中间体 |
HUP0401014A2 (hu) | 2001-07-06 | 2004-08-30 | Teva Pharmaceutical Industries Ltd. | Eljárás 7-amino-szin-3,5-dihidroxi-heptánsavszármazékok előállítására, 6-ciano-szin-3,5-dihidroxi-hexánsav származékokon keresztül |
CZ2004158A3 (cs) | 2001-07-06 | 2005-01-12 | Teva Pharmaceutical Industries Ltd. | Syntéza a meziprodukty derivátů 3,5-dihydroxyheptanové kyseliny |
HUE039881T2 (hu) | 2002-05-09 | 2019-02-28 | Brigham & Womens Hospital Inc | 1L1RL-1, mint egy kardiovaszkuláris betegség-marker |
US20040132771A1 (en) * | 2002-12-20 | 2004-07-08 | Pfizer Inc | Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors |
ATE407670T1 (de) | 2002-12-20 | 2008-09-15 | Pfizer Prod Inc | Dosierungsform enthaltend einen cetp-hemmer und einen hmg-coa reduktase hemmer |
CA2510319A1 (en) | 2002-12-20 | 2004-07-15 | Thomas J. Smith | High pressure compaction for pharmaceutical formulations |
EP1510208A1 (en) | 2003-08-22 | 2005-03-02 | Fournier Laboratories Ireland Limited | Pharmaceutical composition comprising a combination of metformin and statin |
KR20060109926A (ko) | 2003-11-19 | 2006-10-23 | 메타베이시스 테라퓨틱스, 인크. | 새로운 인-함유 갑상선 호르몬 모방약들 |
US7803838B2 (en) * | 2004-06-04 | 2010-09-28 | Forest Laboratories Holdings Limited | Compositions comprising nebivolol |
CA2624601C (en) | 2004-10-06 | 2018-07-03 | The Brigham And Women's Hospital, Inc. | Relevance of achieved levels of markers of systemic inflammation following treatment |
SG175477A1 (en) * | 2005-01-31 | 2011-11-28 | Mylan Lab Inc | Hydroxylated nebivolol metabolites |
AP2896A (en) | 2005-05-31 | 2014-05-31 | Mylan Lab Inc | Compositions comprising nebivolol |
US20090297496A1 (en) * | 2005-09-08 | 2009-12-03 | Childrens Hospital Medical Center | Lysosomal Acid Lipase Therapy for NAFLD and Related Diseases |
US8119358B2 (en) | 2005-10-11 | 2012-02-21 | Tethys Bioscience, Inc. | Diabetes-related biomarkers and methods of use thereof |
US20090069275A1 (en) * | 2006-02-17 | 2009-03-12 | Rocca Jose G | Low flush niacin formulation |
US20080057590A1 (en) | 2006-06-07 | 2008-03-06 | Mickey Urdea | Markers associated with arteriovascular events and methods of use thereof |
ES2532595T3 (es) | 2006-08-30 | 2015-03-30 | Kyushu University, National University Corporation | Composición farmacéutica que contiene una nanopartícula de estatina encapsulada |
JP2010520208A (ja) * | 2007-03-01 | 2010-06-10 | コンコース ヘルス サイエンシーズ エルエルシー | イノシトールナイアシネートの異性体及びその使用 |
AU2008242764B2 (en) | 2007-04-18 | 2013-10-24 | Tethys Bioscience, Inc. | Diabetes-related biomarkers and methods of use thereof |
US20120046364A1 (en) | 2009-02-10 | 2012-02-23 | Metabasis Therapeutics, Inc. | Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use |
SG182821A1 (en) | 2010-02-01 | 2012-08-30 | Hospital For Sick Children | Remote ischemic conditioning for treatment and prevention of restenosis |
SG10201502031XA (en) | 2010-03-31 | 2015-05-28 | Hospital For Sick Children | Use of remote ischemic conditioning to improve outcome after myocardial infarction |
CA2800520A1 (en) | 2010-04-08 | 2011-10-13 | The Hospital For Sick Children | Use of remote ischemic conditioning for traumatic injury |
EP2879666B1 (en) | 2012-08-01 | 2020-04-08 | Tavakoli, Zahra | Free flowing, frozen compositions comprising a therapeutic agent |
SG11201507751YA (en) | 2013-03-21 | 2015-10-29 | Eupraxia Pharmaceuticals USA LLC | Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith |
JP2018531951A (ja) | 2015-10-27 | 2018-11-01 | ユープラシア ファーマシューティカルズ インク. | 局所麻酔薬の徐放性製剤 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2260327A1 (de) * | 1972-12-09 | 1974-06-20 | Hoechst Ag | Neue carbamidsaeureester |
US4434174A (en) * | 1980-02-11 | 1984-02-28 | Berlex Laboratories, Inc. | Treating cardiovascular diseases with N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines |
US4613610A (en) * | 1984-06-22 | 1986-09-23 | Sandoz Pharmaceuticals Corp. | Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives |
US4647576A (en) * | 1984-09-24 | 1987-03-03 | Warner-Lambert Company | Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis |
US4668794A (en) * | 1985-05-22 | 1987-05-26 | Sandoz Pharm. Corp. | Intermediate imidazole acrolein analogs |
JPS6322056A (ja) * | 1986-04-30 | 1988-01-29 | サンド・アクチエンゲゼルシヤフト | オレフイン性化合物の製造法 |
US4714762A (en) * | 1986-10-31 | 1987-12-22 | Warner-Lambert Company | Antiarteriosclerotic substituted benzimidazol-2-yl-and 3H-imidazo[4,5-b]pyridin-2-yl-phenoxy-alkanoic acids and salts and esters thereof |
-
1988
- 1988-07-29 IT IT8821542A patent/IT1226726B/it active
-
1989
- 1989-07-25 EP EP19890201957 patent/EP0352864A3/en not_active Withdrawn
- 1989-07-27 US US07/385,369 patent/US4940800A/en not_active Expired - Fee Related
- 1989-07-28 JP JP89197895A patent/JPH02250870A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0352864A3 (en) | 1991-04-03 |
IT1226726B (it) | 1991-02-05 |
JPH02250870A (ja) | 1990-10-08 |
EP0352864A2 (en) | 1990-01-31 |
US4940800A (en) | 1990-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT8821542A0 (it) | Composti attivi come inibitori della biosintesi del colesterolo. | |
NO871408D0 (no) | Forbedringer ved farmasoeytiske akseptable salter. | |
NO893400D0 (no) | Hiv protease inhibitorer egnet for behandling av aids. | |
NO872589D0 (no) | Noeytrale metalloendopeptidaseinhibitorer for behandling av hypertensjon. | |
FI884924A (fi) | Humanimmuglobulin som producerats med hybrid-dna-teknik. | |
DK317287D0 (da) | Reduktase-inhibitorer | |
DK15689D0 (da) | Sukkerethere som blegestabile renseevneforstaerkere. | |
DE19475001I2 (de) | Anthelminthische Wirkstoffkombinationen. | |
MX9203768A (es) | Inhibidores novedosos de reductasa 3-hidroxi-metilglutaril-coenzima a. | |
NO875239D0 (no) | Fremgangsmaate ved spalting av 1,4-dihydropyridinderivater i optisk aktive isomerer. | |
FI880960A (fi) | Anvaendning av rnas l inhibitor som markeringsaemne i virusinfektioner. | |
IT8547786A1 (it) | Procedimento per ricavare ceftazidima da una soluzione acquosa | |
NO870533D0 (no) | Terapeutisk aktive 3-alkoksy-2-aminopropylaminer. | |
IT1144327B (it) | Composti di inibizione della biosintesi del colesterolo e procedimento per la loro preparazione | |
DE3785689D1 (de) | Verwendung von prostaglandin-biosynthese-hemmer. | |
IT1199140B (it) | Procedimento di trattamento della biomassa | |
ES2056983T3 (es) | Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa. | |
FI883943A (fi) | Modifierade plasminogen-aktivatorer. | |
DK120388D0 (da) | Skab, navnlig badevaerelsesskab | |
IT8841561A0 (it) | Struttura di macchina semolatrice. | |
NO884062D0 (no) | Desinfeksjon av avforminger. | |
FI883254A (fi) | Cytostatiskt aktiva antracyklinderivat. | |
NO884674L (no) | Bleking av tremasse. | |
MX9203486A (es) | (quinolin-2-imetoxi)indol como inhibidores de la biosintesis de leucotrienos). | |
FI883253A (fi) | Cytostatiskt aktiva antracyklinderivat. |